(0)

ViroCyt

ViroCyt is the leader in the field of rapid virus quantification. Our goal is to provide the tools that deliver meaningful improvements to mission critical processes, such as vaccine manufacturing, protein expression, antiviral development and other settings where viruses play a significant role.

Upcoming Event: Viral Quantification Symposium in Boston. Register today: 

 unnamed (3)

Recent News

up
down
  • Virus Quantification Symposium in Boston

    We are excited to announce our upcoming event: Virus Quantification Symposium in Boston. You are cordially invited to join us for a symposium on virus quantification on Tuesday, June 9 from 1pm-6pm at the Joseph B. Martin Conference Center at the Harvard Medical School in Boston, Massachusetts. For more information, please register here: http://goo.gl/YrHJvD

    Read More arrow
  • Personal Invitation to our Webinar

    Dr. Michael Olszowy would like to personally invite you to our upcoming webinar.

    Read More arrow
  • Military Group Uses ViroCyt Technology to Accelerate Ebola Research

    March 11, 8:30 ET Military Group Uses ViroCyt® Technology to Accelerate Ebola Research BOULDER, CO–(Marketwire – March, 2015) – ViroCyt, Inc., the leader in rapid virus quantification, announced today that the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) has published a scientific article in the journal Viruses titled “Evaluation of ViroCyt® Virus Counter®  Continue Reading »

    Read More arrow
  • ViroCyt Wins Colorado BioScience Association’s “Rising Star” Award

    BOULDER, CO–(Marketwire – November, 2014) – ViroCyt, LLC, the leader in rapid virus quantification, announced today that it has received the “Rising Star” award from the Colorado Bioscience Association after being nominated as one of three companies in the category. “The Colorado BioScience Association’s Rising Star award recognizes early stage growth companies that have made great  Continue Reading »

    Read More arrow
  • ViroCyt and I&L Biosystems Launch Virus Counter® 3100 at the World Vaccine Congress in Brussels

    BOULDER, CO–(Marketwire – October, 2014) – ViroCyt, LLC, the leader in rapid virus quantification, announced today that, in partnership with I&L Biosystems GmbH, it is formally launching the Virus Counter® 3100 in Europe at the World Vaccine Congress to be held October 13-15 in Brussels, Belgium. “The Virus Counter 3100 is the marquee analytical tool for  Continue Reading »

    Read More arrow

Upcoming Events


May
6

Virus Quantification Symposium – Germany Event Details

May
12

LIVE WEBINAR: Register today! Event Details

May
13

American Society of Gene and Cell Therapy Annual Meeting Event Details

Jun
9

Upcoming Event: Virus Quantification Symposium Event Details

Sep
28

ISBioTech 3rd Annual Fall Meeting Event Details